MMP9 and breast carcinoma: The S100A1+subpopulation promotes a pro-inflammatory microenvironment and accelerates angiogenesis and matrix remodeling by releasing leukotriene B4(LTB4), ROS, and matrix metalloproteinase-9(MMP9), directly facilitating breast cancer metastasis.